Invention Grant
- Patent Title: Antibody against the endothelin receptor subtype A, and uses thereof
-
Application No.: US16967763Application Date: 2019-02-04
-
Publication No.: US12084505B2Publication Date: 2024-09-10
- Inventor: Didier Boquet , Amaury Herbet , Frederic Ducancel , Narciso Costa , Jean-Yves Couraud , Jean-Philippe Hugnot
- Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES , Universite de Paris , UNIVERSITE DE MONTPELLIER , Institut National de la Sante et de la recherche Medicale
- Applicant Address: FR Paris
- Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,UNIVERSITÉ PARIS CITÉ,UNIVERSITE DE MONTPELLIER,Institut National de la Sante et de la recherche Medicale
- Current Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,UNIVERSITÉ PARIS CITÉ,UNIVERSITE DE MONTPELLIER,Institut National de la Sante et de la recherche Medicale
- Current Assignee Address: FR Paris; FR Paris; FR Montpellier; FR Paris
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: FR 51026 2018.02.07
- International Application: PCT/FR2019/050245 2019.02.04
- International Announcement: WO2019/155151A 2019.08.15
- Date entered country: 2020-08-06
- Main IPC: G01N33/74
- IPC: G01N33/74 ; C07K16/28 ; G01N33/574
Abstract:
The present invention relates to antibodies against the endothelin receptor subtype A, in particular monoclonal antibodies, fragments or derivatives thereof. The present invention also relates to the therapeutic or diagnostic use of this antibody or as a research tool in the field of cancers, in particular glioblastoma.
Public/Granted literature
- US20220089755A1 ANTIBODY AGAINST THE ENDOTHELIN RECEPTOR SUBTYPE A, AND USES THEREOF Public/Granted day:2022-03-24
Information query
IPC分类:
